Chemotherapy, Hypothyroidism and Oral Dysbiosis As a Novel Risk Factor of Cardiovascular Pathology Development Publisher Pubmed



Avagimyan A¹ ; Gvianishvili T² ; Gogiashvili L³ ; Kakturskiy L⁴ ; Sarrafzadegan N⁵ ; Aznauryan A⁶
Source: Current Problems in Cardiology Published:2023

Abstract

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the population, as well as the economic burden of the health care system. Currently, CVDs account for more than 17.6 million deaths a year and are projected to exceed 23.6 million by 2030. Unstable atheroma, and its rupture, underlies the pathology of most cardiovascular complications, particularly acute coronary syndrome, mortality from which, compared with other CV events, remains the leading one. Despite numerous efforts by WHO, national health systems, and medical authorities, the incidence and mortality from cardiovascular events remain critically high. Thus, the search for new risk factors for the development of CV pathology looks very relevant. Our working group decided to amalgamate our research data, which reflects the study of modern risk factors from the Armenian, Russian, Georgian, and Iranian medical schools. In particular, the aspects of cardiotoxic effects of chemotherapy, hypothyroidism, and oral dysbiosis are discussed. © 2021 Elsevier Inc.